A two year study involving a new formulation of Rebif reported a marked increase in injection tolerability. The new formulation was approved by the European Commision in August and will be available to patients in the UK by early 2008.
Your email is never published nor shared. Required fields are marked *
You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
Reformulated Rebif Offers Improved Injection Tolerability
A two year study involving a new formulation of Rebif reported a marked increase in injection tolerability. The new formulation was approved by the European Commision in August and will be available to patients in the UK by early 2008.